251 related articles for article (PubMed ID: 22893265)
1. Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.
Wang Q; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
Arch Neurol; 2012 Nov; 69(11):1454-60. PubMed ID: 22893265
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
Yi X; Lin J; Wang C; Zhang B; Chi W
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1537-44. PubMed ID: 24656240
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
Wong KS; Chen C; Ng PW; Tsoi TH; Li HL; Fong WC; Yeung J; Wong CK; Yip KK; Gao H; Wong HB;
Lancet Neurol; 2007 May; 6(5):407-13. PubMed ID: 17434095
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
Wang QS; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
Stroke; 2012 Feb; 43(2):346-9. PubMed ID: 22076004
[TBL] [Abstract][Full Text] [Related]
5. Frequency of microemboli signal in stroke patients treated with low molecular weight heparin or aspirin.
Hao Q; Chang HM; Wong MC; Wong KS; Chen C
J Neuroimaging; 2010 Apr; 20(2):118-21. PubMed ID: 19141068
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic review.
Bath P; Leonardi-Bee J; Bath F
J Stroke Cerebrovasc Dis; 2002; 11(2):55-62. PubMed ID: 17903857
[TBL] [Abstract][Full Text] [Related]
7. Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Xia H; Wang Z; Tian M; Liu Z; Zhou Z
Front Immunol; 2022; 13():823391. PubMed ID: 35281068
[TBL] [Abstract][Full Text] [Related]
8. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
10. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
[TBL] [Abstract][Full Text] [Related]
11. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
12. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
13. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis.
Kiphuth IC; Staykov D; Köhrmann M; Struffert T; Richter G; Bardutzky J; Kollmar R; Mäurer M; Schellinger PD; Hilz MJ; Doerfler A; Schwab S; Huttner HB
Cerebrovasc Dis; 2009; 27(2):146-50. PubMed ID: 19039218
[TBL] [Abstract][Full Text] [Related]
14. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
[TBL] [Abstract][Full Text] [Related]
15. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
Dumaine R; Borentain M; Bertel O; Bode C; Gallo R; White HD; Collet JP; Steinhubl SR; Montalescot G
Arch Intern Med; 2007 Dec; 167(22):2423-30. PubMed ID: 18071163
[TBL] [Abstract][Full Text] [Related]
16. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
[TBL] [Abstract][Full Text] [Related]
17. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
Sarma GR; Roy AK
Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005
[TBL] [Abstract][Full Text] [Related]
18. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
19. Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis.
Busch M; Masuhr F
Eur J Med Res; 2004 Apr; 9(4):199-206. PubMed ID: 15210400
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
